Clinical Advisory Network on Sex and Gender
First Do No Harm Critical perspectives on sex and gender in healthcare With over 150 attendees, and hundreds from across the world joining the livestream, #FirstDoNoHarm was a resounding success. The sold-out event platformed and hosted clinicians and patients from around the UK, Europe and the US. The conference footage will be free to watch […]
The review of the literature found that no well-designed studies have ever been conducted to properly assess the impact of puberty blockers on cognitive function.
Our current understanding of the importance of puberty in the development of cognitive function, animal studies and very limited data from human studies do not support the notion that puberty blockers have no impact on cognitive development or that any effects are reversible.
Indeed, the evidence to date points in the other direction.
BREAKING Extended deadline for feedback on development of a WHO guideline on the health of trans and gender diverse people. Submissions now close 2 Feb 2024 In June 2023, the World Health Organisation (WHO) announced it was planning to develop a guideline on the health of trans and gender diverse people; a further notice on 18 December […]